CEO: Keith R. Leonard

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Unity Biotechnology Inc operates as a biotechnology company. The firm focuses on age-associated diseases such as arthritis, vision loss and cognitive decline.


Key numbers

Market Capitalization:282547620
Shares Outstanding: 43203000
Float: 21319341.207000002
Next Earning Date:2020-03-04
TTm EPS: -2.0396
TTm Dividend Rate:
200 days moving average:7.99
50 days moving average: 6.79
One day percent Change: 5.96



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2016-12-31, 2017-12-31, 2018-12-31,
2016-12-31, 2017-12-31, 2018-12-31,